Astrazeneca US vaccine trial remains on hold in US as regulators probe side effect

Author: Adam Button | Category: News

Risk assets dip on the headline

Astrazeneca was in the news last week after a UK trial participant was hospitalized with side effects. The trial there resumed this week but it remains halted in the US as regulators there examine the case.

I can't see this derailing today's price action but there are some jitters at the moment with stocks at the lowest levels since the open.

For bank trade ideas, check out eFX Plus
By continuing to browse our site you agree to our use of cookies, revised Privacy Notice and Terms of Service. More information about cookiesClose